Julie Vackova

Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation

R. Tachezy, I. Poláková, M. Šmahel, 2018, International journal of molecular sciences.

The effect of clinically relevant doses of immunosuppressive drugs on human mesenchymal stem cells.

A. Zajícová, V. Holan, E. Javorkova, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules.

I. Poláková, M. Šmahel, Adrianna Grzelak, 2019, Oncology reports.

Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade

I. Poláková, M. Šmahel, Julie Vackova, 2020, International journal of molecular sciences.

CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade

I. Poláková, M. Šmahel, Julie Vackova, 2021, Cancers.